S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ICUI · ICU Medical, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$160.81
-0.37
(-0.23%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$160.81
$160.20
$161.81
52-WEEK RANGE
$160.81
$113.37
$192.85
What's happening
- ICUI is down 0.23% today, trading at $160.81. — Live quote
- Volume today (15,754) is well below its 3-month average of 280,490. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.37 actual vs. $1.95 estimated (+21.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 7
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ICUI
+12.90%
vs S&P 500
+0.13%
1-YEAR RETURN
ICUI
+37.28%
vs S&P 500
+22.71%
6-MONTH RETURN
ICUI
+27.80%
3-MONTH RETURN
ICUI
+1.45%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$2.37
Est. $1.95
BEAT +21.4%
2026-04-26 (Q1 2026)
$1.97
Est. $1.79
BEAT +10.3%
2026-01-26 (Q4 2025)
$1.91
Est. $1.73
BEAT +10.7%
2025-10-26 (Q3 2025)
$2.03
Est. $1.46
BEAT +38.9%
Valuation Measures & Ratios
Enterprise Value4$4.96B
Forward P/E517.20
PEG Ratio6—
Price / Sales (TTM1)1.86
Price / Book71.70
EV4 / Revenue2.30
EV4 / EBITDA64.10
Profit Margin1.39%
Operating Margin3.47%
Return on Equity (ROE8)1.41%
Return on Assets (ROA9)0.75%
Avg Volume (3M)280,490
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.71B | $3.25B | $2.91B | $3.26B | $3.40B |
| P/E | 45.72 | 69.65 | -176.20 | -94.54 | -31.11 |
| Price/Sales | 1.71 | 1.46 | 1.28 | 1.40 | 1.44 |
| Price/Book | 1.72 | 1.54 | 1.37 | 1.54 | 1.71 |
| EV/Revenue | 2.28 | 2.04 | 1.85 | 1.97 | 2.09 |
| EV/EBITDA | 17.83 | 18.05 | 16.83 | — | — |
| ROE | 3.77% | 2.21% | -0.78% | -1.63% | -5.50% |
| ROA | 2.04% | 1.16% | -0.40% | -0.84% | -2.61% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,523,113
Change from Prior Settlement+0.49%
% of Float—
Days to Cover (Short Ratio)5.44
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 0.5% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +37.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 1.4%. Finnhub fundamentals ↗
- Trailing P/E is 133.8, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-03; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ICUI
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $551.7M | $530.2M | $537.0M | $548.9M | $604.7M | $589.1M | $596.5M | $566.7M |
| Gross profit | $235.1M | $206.2M | $200.9M | $208.1M | $210.1M | $204.9M | $207.4M | $185.2M |
| Operating income | $39.1M | $13.6M | $13.7M | $10.6M | $12.9M | $8.2M | $7.7M | -$10.7M |
| Net income | $19.1M | $30.1M | -$3.4M | $35.3M | -$15.5M | -$33.0M | -$21.4M | -$39.5M |
| EPS (diluted) | $0.76 | $1.20 | $-0.14 | $1.43 | $-0.63 | $-1.35 | $-0.88 | $-1.63 |
| EPS (basic) | $0.76 | $1.22 | $-0.14 | $1.43 | $-0.63 | $-1.35 | $-0.88 | $-1.63 |
| Operating margin | $7 | $3 | $3 | $2 | $2 | $1 | $1 | -$2 |
| Net margin | $3 | $6 | -$1 | $6 | -$3 | -$6 | -$4 | -$7 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B |
| Stockholders' equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B |
| Total current assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B |
| Total current liabilities | $498.4M | $517.9M | $498.9M | $492.9M | $482.8M | $549.0M | $556.2M | $549.6M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | $183.5M | $201.1M | $180.5M | $191.5M | $179.5M | $170.9M | $182.8M | $174.0M |
| Inventory | $607.4M | $605.6M | $615.9M | $622.4M | $616.5M | $590.3M | $584.7M | $692.0M |
| Other current assets | $34.4M | $38.6M | $25.5M | $23.1M | $23.3M | $5.6M | $22.6M | $4.6M |
| Property, plant & equipment | $446.8M | $445.1M | $451.8M | $456.0M | $452.4M | $442.0M | $442.7M | $595.6M |
| Goodwill | $1.48B | $1.49B | $1.50B | $1.50B | $1.50B | $1.46B | $1.43B | $1.48B |
| Intangible assets | $567.7M | $599.0M | $633.6M | $664.8M | $698.0M | $716.7M | $740.8M | $785.8M |
| Other non-current assets | $63.4M | $63.5M | $62.9M | $61.4M | $61.3M | $64.6M | $65.1M | $86.8M |
| Accounts payable | $149.2M | $174.0M | $154.4M | $171.8M | $168.8M | $180.4M | $148.0M | $168.6M |
| Accrued liabilities | $322.5M | $314.6M | $315.3M | $316.1M | $313.8M | $278.9M | $306.9M | $325.7M |
| Deferred revenue (current) | — | — | $33.8M | — | — | — | $30.4M | — |
| Short-term debt | $18.8M | $18.8M | $18.8M | $0 | $0 | $47.8M | $51.0M | $51.0M |
| Long-term debt | $1.21B | $1.26B | $1.27B | $1.31B | $1.34B | $1.49B | $1.53B | $1.54B |
| Other non-current liabilities | $71.0M | $82.3M | $89.5M | $93.6M | $96.3M | $77.6M | $66.7M | $80.4M |
| Common stock & paid-in capital | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.4M |
| Retained earnings | $740.1M | $721.0M | $690.9M | $706.6M | $710.0M | $674.7M | $690.2M | $714.0M |
| Accumulated other comprehensive income (loss) | -$43.3M | -$51.9M | -$34.6M | -$33.0M | -$32.6M | -$105.4M | -$139.4M | -$62.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.2M | $38.9M | $60.6M | $56.7M | $11.2M | $51.3M | $40.2M | $36.1M |
| Investing cash flow | -$20.1M | -$11.2M | -$18.4M | -$30.0M | $187.5M | -$16.8M | -$26.5M | -$22.9M |
| Financing cash flow | -$50.2M | -$44.1M | -$34.5M | -$25.7M | -$195.0M | -$56.3M | -$8.2M | -$10.4M |
| Free cash flow | $61.6M | $27.6M | $36.0M | $27.6M | -$8.5M | $36.7M | $16.1M | $16.2M |
| Capital expenditures | $18.5M | $11.3M | $24.6M | $29.1M | $19.7M | $14.6M | $24.1M | $19.9M |
| Depreciation & amortization | $49.6M | $50.0M | $50.8M | $50.8M | $49.7M | $49.4M | $53.0M | $55.7M |
| Share-based compensation | $11.9M | $14.0M | $13.9M | $15.2M | $14.5M | $12.2M | $12.5M | $11.8M |
| Deferred income taxes | — | — | -$13.8M | — | — | — | $5.7M | — |
| Change in accounts receivable | -$16.6M | $24.1M | -$4.9M | $12.7M | $5.7M | -$22.4M | $35.3M | $18.2M |
| Change in inventory | $1.5M | -$6.1M | -$10.0M | $7.0M | $21.0M | $8.2M | -$7.4M | $11.7M |
| Change in accounts payable | -$25.1M | $20.1M | -$16.3M | $8.9M | -$17.7M | $32.1M | -$8.6M | $11.7M |
| Purchases of investments | — | — | — | — | — | — | $0 | — |
| Share repurchases | — | — | $8.8M | — | — | — | $12.0M | — |
| Debt repaid | $50.0M | $4.7M | $30.0M | $25.0M | $200.0M | $47.8M | $12.8M | $12.8M |
| Tax withholding on stock comp | $86.0K | $38.8M | $81.0K | $31.0K | $297.0K | $8.4M | $133.0K | $182.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Gross profit | $822.0M | $824.8M | $739.9M | $697.8M | $491.5M |
| Operating income | $42.8M | $43.0M | $22.8M | -$42.9M | $123.2M |
| Net income | $732.0K | -$117.7M | -$29.7M | -$74.3M | $103.1M |
| EPS (diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| EPS (basic) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 |
| Operating margin | $2 | $2 | $1 | -$2 | $9 |
| Net margin | $0 | -$5 | -$1 | -$3 | $8 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B |
| Stockholders' equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B |
| Total current assets | $1.19B | $1.44B | $1.22B | $1.24B | $1.03B |
| Total current liabilities | $498.9M | $556.2M | $481.8M | $494.6M | $200.8M |
| Cash & equivalents | — | — | — | $208.8M | $552.8M |
| Accounts receivable | $180.5M | $182.8M | $161.6M | $221.7M | $105.9M |
| Inventory | $615.9M | $584.7M | $709.4M | $696.0M | $290.2M |
| Other current assets | $20.5M | $22.6M | $3.7M | $3.5M | $2.2M |
| Property, plant & equipment | $451.8M | $442.7M | $612.9M | $636.1M | $468.4M |
| Goodwill | $1.50B | $1.43B | $1.47B | $1.45B | $43.4M |
| Intangible assets | $633.6M | $740.8M | $870.6M | $982.8M | $188.3M |
| Other non-current assets | $62.9M | $65.1M | $94.0M | $105.5M | $63.7M |
| Accounts payable | $154.4M | $148.0M | $150.0M | $215.9M | $81.1M |
| Accrued liabilities | $315.3M | $306.9M | $268.2M | $242.8M | $118.2M |
| Deferred revenue (current) | $33.8M | $30.4M | $31.6M | $30.8M | $12.6M |
| Short-term debt | $18.8M | $51.0M | $51.0M | $29.7M | $0 |
| Long-term debt | $1.27B | $1.53B | $1.58B | $1.62B | — |
| Common stock & paid-in capital | $2.5M | $2.5M | $2.4M | $2.4M | $2.1M |
| Retained earnings | $690.9M | $690.2M | $807.8M | $837.5M | $911.8M |
| Accumulated other comprehensive income (loss) | -$34.6M | -$139.4M | -$53.1M | -$81.0M | -$19.3M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $179.8M | $204.0M | $166.2M | -$62.1M | $267.5M |
| Investing cash flow | $122.2M | -$89.0M | -$87.9M | -$1.91B | -$90.7M |
| Financing cash flow | -$311.5M | -$55.8M | -$36.0M | $1.64B | -$16.9M |
| Free cash flow | $91.8M | $124.7M | $82.3M | -$152.4M | $199.0M |
| Capital expenditures | $88.0M | $79.4M | $83.9M | $90.3M | $68.5M |
| Depreciation & amortization | $200.7M | $219.5M | $228.8M | $235.2M | $89.7M |
| Share-based compensation | $55.8M | $46.9M | $40.6M | $36.0M | $27.3M |
| Deferred income taxes | -$13.8M | $5.7M | -$69.9M | -$61.0M | -$11.3M |
| Change in accounts receivable | -$8.9M | $46.8M | -$48.6M | $19.2M | -$13.8M |
| Change in inventory | $26.3M | -$16.8M | $6.1M | $201.1M | -$20.8M |
| Change in accounts payable | $7.0M | $12.5M | -$68.3M | $37.5M | $2.3M |
| Purchases of investments | — | $0 | $0 | $3.4M | $10.0M |
| Share repurchases | $8.8M | $12.0M | $9.3M | $10.9M | $8.3M |
| Debt repaid | $302.8M | $51.0M | $29.7M | $22.4M | $0 |
| Tax withholding on stock comp | $8.8M | $12.0M | $9.4M | $10.9M | $8.3M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ICUI as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-07 to 2026-09-03
Recent transactions
- Insiders have net sold 44,512 shares over the last 182 days, across 0 purchases and 16 sales.
- Most recent: Sanzone Virginia Ruth (VP, General Counsel) — Open market sale of 2,202 shares on 2026-09-03.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)44,512 sh(16 txns)
Net Shares-44,512
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 2026-09-03 | 2,202 |
| Bonnell Brian Michael | Chief Financial Officer | Open market sale | 2026-09-01 | 6,381 |
| Woolson Daniel | VP, GM-Infusion Capital | Open market sale | 2026-08-13 | 5,417 |
| Sousa Ben | Chief Information Officer | Open market sale | 2026-08-12 | 2,250 |
| Voigtlander Christian B. | Chief Operating Officer | Open market sale | 2026-08-11 | 8,929 |
| FINNEY ELISHA W | Director | Open market sale | 2026-08-11 | 378 |
| KENNEDY KOLLEEN T | Director | Option exercise | 2026-05-13 | 1,254 |
| Hernandez Laurie | Director | Option exercise | 2026-05-13 | 1,254 |
| Abbey Donald | Director | Option exercise | 2026-05-13 | 1,254 |
| Hoffmeister David F | Director | Option exercise | 2026-05-13 | 1,254 |
| Greenberg David C. | Director | Option exercise | 2026-05-13 | 1,254 |
| Jain Vivek | Chairman and CEO | Option exercise | 2026-03-15 | 17,100 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 2,202 | $167.67 |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 1,238 | $168.44 |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 724 | $169.53 |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 692 | $171.51 |
| 2026-09-01 | Bonnell Brian Michael | Chief Financial Officer | Open market sale | 6,381 | $175.00 |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Open market sale | 1,712 | $171.05 |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Open market sale | 1,914 | $172.12 |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Open market sale | 4,568 | $173.44 |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Open market sale | 1,113 | $173.91 |
| 2026-08-13 | Woolson Daniel | VP, GM-Infusion Capital | Open market sale | 5,417 | $181.33 |
| 2026-08-12 | Sousa Ben | Chief Information Officer | Open market sale | 2,250 | $178.32 |
| 2026-08-11 | Voigtlander Christian B. | Chief Operating Officer | Open market sale | 8,929 | $182.93 |
| 2026-08-11 | FINNEY ELISHA W | Director | Open market sale | 378 | $182.48 |
| 2026-05-22 | Woolson Daniel | President | Open market sale | 2,123 | $132.21 |
| 2026-05-14 | Sanzone Virginia Ruth | VP, General Counsel | Open market sale | 2,447 | $124.08 |
| 2026-05-13 | KENNEDY KOLLEEN T | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-13 | Hernandez Laurie | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-13 | FINNEY ELISHA W | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-13 | Abbey Donald | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-13 | Hoffmeister David F | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-13 | Greenberg David C. | Director | Option exercise | 1,254 | $0.00 |
| 2026-05-12 | Greenberg David C. | Director | Option exercise | 2,424 | $101.06 |
| 2026-05-12 | Greenberg David C. | Director | Open market sale | 2,424 | $122.91 |
| 2026-03-25 | Abbey Donald | Director | Other acquisition/disposition | 704 | $0.00 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 11,400 | $0.00 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 6,301 | $125.85 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 3,248 | $0.00 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 1,795 | $125.85 |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Option exercise | 2,924 | $0.00 |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 1,295 | $125.85 |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Option exercise | 1,300 | $0.00 |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Tax withholding | 718 | $125.85 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 5,700 | $0.00 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 3,150 | $125.85 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 1,624 | $0.00 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 897 | $125.85 |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Option exercise | 17,100 | $0.00 |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 9,452 | $125.85 |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Option exercise | 4,872 | $0.00 |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 2,693 | $125.85 |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 11,400 | $0.00 |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 5,800 | $125.85 |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 3,248 | $0.00 |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 1,795 | $125.85 |
| 2026-03-08 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 71,757 | $0.00 |
| 2026-03-08 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 39,667 | $132.00 |
| 2026-03-08 | Jain Vivek | Chairman and CEO | Option exercise | 107,635 | $0.00 |
| 2026-03-08 | Jain Vivek | Chairman and CEO | Tax withholding | 59,500 | $132.00 |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Option exercise | 7,177 | $0.00 |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 3,967 | $132.00 |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Option exercise | 957 | $0.00 |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 529 | $132.00 |
| 2026-03-07 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 3,522 | $0.00 |
| 2026-03-07 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 1,263 | $0.00 |
| 2026-03-07 | Jain Vivek | Chairman and CEO | Option exercise | 5,282 | $0.00 |
| 2026-03-07 | Jain Vivek | Chairman and CEO | Tax withholding | 2,919 | $0.00 |
| 2026-03-07 | Sousa Ben | Chief Information Officer | Option exercise | 1,409 | $0.00 |
| 2026-03-07 | Sousa Ben | Chief Information Officer | Tax withholding | 782 | $132.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:12 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-03 | 4 | 2026-09-03 | View on SEC.gov → |
| 2026-09-01 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-31 | 4 | 2026-08-31 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-13 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-12 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-05-22 | 4 | 2026-05-22 | View on SEC.gov → |
| 2026-05-18 | 8-K | 2026-05-13 | View on SEC.gov → |
| 2026-05-15 | 4 | 2026-05-14 | View on SEC.gov → |
Recent news
Headlines about ICUI (ICU Medical, Inc.). Links open the publisher — we don’t host full articles.
-
Argus raises target for ICU Medical stock to USD 171.00
AD HOC NEWS · 2026-10-20 -
APP,AD,NEGG,PSX,SGI,PRCT,ICUI,UA | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-18 -
ICU Medical, Inc. (ICUI) Stock forecasts
Yahoo Finance UK · 2026-10-18 -
ICUI270219C00120000 Interactive Stock Chart | ICUI Feb 2027 120.000 call Stock
Yahoo! Finance Canada · 2026-10-18 -
ICU Medical stock faces an 18.29 percent gap to USD 192.80 target
AD HOC NEWS · 2026-10-17 -
ICU Medical is due to report November 5, 2026: what it means for ICU Medical stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-15 -
ICUI Oct 2026 150.000 put (ICUI261016P00150000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-15 -
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
Yahoo · 2026-10-12
No headlines in this category right now — try “All”.